1Poynard T, Mathurin P, Lai C L, et al. A comparison of fi- brosis progression in chronic liver diseases[J]. J Hepatol, 2003, 38 (3): 257-265.
2Saleh H A, Abu-Rashed A H. Liver biopsy remains the gold standard for evaluation of chronic hepatitis and fibrosis [J]. J Gastrointestin Liver Dis, 2007, 16 (4): 425-426.
4Scott D R, Levy M T. Liver transient elastography (FibreS- can) : a place in the management algorithms of chronic viral hep- atitis [J]. Antivir Ther, 2010, 15 (1): 1-11.
5Takemoto R, Nakamuta M, Aoyagi Y, et al. Validity of Fi- hroScan values for predicting hepatic fibrosis stage in patients with chronic HCV infection[J]. J Dig Dis, 2009, 101 (2): 145-148.
二级参考文献39
1Benyon RC, Arthur MJ. Extracellular matrix degradation and the role of hepatic stellate cells[J]. Semin Liver Dis, 2001, 21(3):373- 384.
2Walsh KM, Fletcher A, MacSween RN, et al. Basement membrane peptides as markers of liver disease in chronic hepatitis C [J]. JHepatol, 2000, 32(2):325-330.
3Roderfeld M, Hemmann S, Roeb E. Mechanisms of fibrinolysis in chronic liver injury (with special emphasis on MMPs and TIMPs) [J]. Z Gastroenterol, 2007, 45(1):25-33.
4Boeker KH, Haberkorn CI, Michels D, et al. Diagnostic potential of circulating TIMP-1 and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C[J]. Clin Chim Acta, 2002, 316(1-2): 71-81.
5Schwettmann L, Wehmeier M, Jokovic D, et al. Hepatic expression of a disintegrin and metalloproteinase (ADAM) and ADAMs with thrombospondin motives (ADAM-TS) enzymes in patients with chronic liver diseases[J]. J Hepatol, 2008, 49(2):243-250.
6Fontana R J, Goodman ZD, Dienstag JL, et al. Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C[J]. Hepatology, 2008, 47 (3):789-798.
7Poynard T, Morra R, Halfon P, et al. Meta-analyses of FibroTest diagnostic value in chronic liver disease[J]. BMC Gastroenterol, 2007, 7:40.
8Shaheen AA, Myers RP. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review[J]. Hepatology, 2007, 46(3): 912-921.
9Carvalho-Filho RJ, Schiavon LL Narciso-Schiavon JL et al. Optimized cut-offs improve performance of the aspartate aminotransfe- rase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection[J]. Liver Int, 2008, 28(4):486-493.
10Schiavon LL, Schiavon JL, Filho R J, et al. Simple blood tests as noninvasive markers of liver fibrosis in hemodialysis patients with chronic hepatitis C virus infection[J]. Hepatology, 2007, 46(2):307- 314.
